PR002702 (Project)

Description:Bone-related conditions are a leading cause of disability and rising healthcare costs, prompting interest in tissue engineering solutions using mesenchymal stem cells (MSC). As part of an effort to eliminate synthetic osteogenic compounds, this study characterizes the metabolic adaptations of MSC to chemical-free nanovibration (or nanokicking, NK)-induced osteodifferentiation. Through articulation of conventional gene markers and a global metabolomics/lipidomics strategy, our findings indicate successful slow-paced osteodifferentiation, expressed by subtle and partially reversible intracellular changes, and pronounced, largely irreversible, extracellular alterations.